Business & Regulation

There are many players in pharmaceutical pricing, from drug manufacturers to PBMs and pharmacies. Who should take the lead?

Hall Gregg, Chief Portfolio Officer at the Pistoia Alliance, discusses the transformative power of collaboration, innovation, and diversification

What can science learn from patients, and how can patients benefit from being in control of their own health?

Patient-centricity needs to be more than a buzzword. Here’s how Boehringer Ingelheim is weaving it into its culture.

The wait is over. Our annual celebration of the pharma industry’s most influential individuals has returned!

Do investors scrutinize pharma CEOs more closely when they are women?

In Britain and around the world, the investment ecosystem dominated by males needs an urgent shake up.

A new class of modern cloud systems promises the next step change in QC productivity and data integrity.

What does social media have to say about Eli Lilly’s insulin price reduction?

A video interview covering supply chain improvement technology